Heart Failure 2017 - 4th World Congress on Acute Heart Failure

29 April - 02 May 2017, Paris - France

Session Details

Poster Session 4: Chronic heart failure
Tue 02 May 08:00 - 12:30 Miscellaneous Poster Session Poster Area -

Access slides, videos, reports online via ESC Congress 365 Other resources

List of Presentations

Time
 
FP Nr
 
Title
 
Speakers
 
Related documents
08:00P2147Cardiac coherence by breathing in heart failure patients during cardiac rehabilitation 
08:00P2148Cardiopulmonary exercise testing, right heart catheterization and etiology of heart failureMagdalena DUDEK (Poznan, Poland)
08:00P2149Determinants of cardiovascular death risk in dialysis patients.Merita RROJI (Tirana, Albania)
08:00P2150The effects of ferrous sulfate supplementation on left ventricular intrinsic function by global longitudinal strain in systolic heart failure patient with iron deficiency anaemia 
08:00P2151Body composition in heart failure and chronic obstructive pulmonary disease patientsAna Grecia NAVARRETE PENALOZA (Puebla, Mexico)
08:00P2152Association of diastolic dysfunction and cognitive function in heart failureMi-Seung SHIN (Incheon, Korea Republic of)
08:00P2153Interventions to enhance medication adherence in older heart failure patients, a systematic reviewRoberta FULTON (Dundee, United Kingdom)
08:00P2154Patients in nyha III report substantial limitation to routine daily activities which may not be related to heart failureRenata Rodrigues CASTRO (Brookline, United States of America)
08:00P2155Predictors of 6- and 12-month mortality in chronic heart failureNataliya TKACH (Kiev, Ukraine)
08:00P2156The role of hibernation in potential recovery of ischemic myocardium in chronic heart failure as a manifestation of coronary artery diseaseElena STEFANOVIC (Belgrade, Serbia)
08:00P2157Metabolic treatment elderly patients with congestive heart failure with preserved systolic function and non severe aortic stenosisOlena SOYA (Dnepropetrovsk, Ukraine)
08:00P2158Rheumatoid arthritis and congestive heart failureTheodoros MICHAILIDIS (Alexandria, Greece)
08:00P2159Heart failure development and rs2274273 in the vicinity of LGALS-3 locus, LGALS-3 relative mRNA expression in patients with first myocardial infarctionMilica DEKLEVA (Belgrade, Serbia)
08:00P2160The relationship between blood pressure, heart rate and clinical status in patients with chronic heart failure with reduced left ventricular ejection fractionMichal BOHDAN (Gdansk, Poland)
08:00P2162Liver dysfunction at chronic heart failure patientsKaoutar KHARBOUCHE (Casablanca, Morocco)
08:00P2163Cardiac resynchronization therapy in heart failure patientsRahma KALLEL (Sfax, Tunisia)
08:00P2164Myopathy and iron deficiency in chronic heart failure: dynamic 31P MR spectroscopy study of the skeletal muscle Katerina HLAVATA (Prague, Czech Republic)
08:00P2165Assessment of causes of increased myocardial fibrosis, left ventricular dysfunction and poor prognosis after valve replacement for acquired heart diseaseIrina AVERINA (Moscow, Russian Federation)
08:00P2166Predictors of left ventricular function recovery in patients followed in a heart failure clinicHenrique GUEDES (Vila Nova De Gaia, Portugal)
08:00P2167Heart failure as predictor of sudden death in patients with myocardial infarction after prior CABG; 27-year experience Predrag MITROVIC (Beograd, Serbia)
08:00P2168ST2 in HFpEF and HFrEF, similarities and differencesEmil NAJJAR (Sodertalje, Sweden)
08:00P2169Increasing the efficiency of treatment of patients with chronic heart failure through the changes of control systems of patients.Igor FOMIN (Nizhni Novgorod, Russian Federation)
08:00P2170Utilization of evidence based therapies in patients hospitalized for worsening heart failureCrina Ioana RADULESCU (Babadag, Romania)
08:00P2171B-natriuretic peptide and its prognostic value in coronary patients with heart failure, irrespectively of renal function; the interaction with heart failure phenotype; hellenic heart failure studyChristina CHRYSOHOOU (Athens, Greece)
08:00P2172Red cell distribution width change during hospitalisation and 1-year mortality in chronic heart failurePavel LAZAREV (Moscow, Russian Federation)
08:00P2173Left ventricular dysfunction and cardiac outcomes one year after successful percutaneous coronary intervention in patients with acute ST elevation myocardial infarctionHui-Jeong HWANG (Seoul, Korea Republic of)
08:00P2174Heart failure with mid-range ejection fraction: clinical profile and mid-term outcome.Jose Manuel GARCIA-PINILLA (Malaga, Spain)
08:00P2175Precipitants of ADHF in era of disease management programsFaizan RATHORE (Skerries Co.Dublin, Ireland)
08:00P2176Sleep disordered breathing (SDB) in heart failure with preserved ejection fraction (HFpEF) the tip of the icebergArantxa BARANDIARAN (Maastricht, Netherlands)
08:00P2177Management of patients with chronic heart failure and mid-range left ventricular ejection fractionAlena KURLIANSKAYA (Minsk, Belarus)
08:00P2178Initial experience from a novel service for the initiation and uptitration of sacubitril/valsartanRichard CRAWLEY (Portsmouth, United Kingdom)
08:00P2179Does allopurinol have any benefit in heart failure patients without hyperuricemia?Mohammad Mostafa ANSARI-RAMANDI (Tehran, Iran (Islamic Republic of))
08:00P2180Patient reported outcomes, health service utilisation and place of care/death for advanced heart failure patients attending a palliative cardiology clinic or receiving usual care: a feasibility studyMiriam Jane JOHNSON (Hull, United Kingdom)
08:00P2181Reducing hospital readmissions in heart failure patients: preliminary data from Azienda USL Toscana Centro heart failure pathway 
08:00P2182Factors of improvement of physical ability after exercice training program in heart failure patients with reduced ejection fractionElodie GEORGE (Reims, France)
08:00P2183Heart failure virtual consultation - a mixed methods evaluationChris WATSON (Belfast, United Kingdom)
08:00P2184Rationale and design of PREFER: a prospective evaluation of natriuretic peptide based referral of chronic heart failure patients in primary careRichard HOBBS (Oxford, United Kingdom)
08:00P2185Reliability of peripheral arterial tonometry for assessment of endothelial function in patients with heart failure with preserved and reduced ejection fraction, diabetic nephropathy and arterial hyperHans-Dirk DUENGEN (Berlin, Germany)
08:00P2186An algorithm to screen for left ventricular systolic dysfunction in the elderly, based on specific ECG-changes, NT-proBNP and handheld echocardiographyLine Lisbeth OLESEN (Roskilde, Denmark)
08:00P2187Association of serum ADAM-10 with cognitive function in patients with stable chronic heart failureSonja Maria WEDEGAERTNER (Homburg/Saar, Germany)
08:00P2188Assessment of syndecan-4 expression in the hearts of mice and human subjects with chronic chagas cardiomyopathyCarolina MACEDO (Salvador, Brazil)
08:00P2189Analysis of mirna alterations in subjects with chronic chagas disease cardiomyopathyCarolina MACEDO (Salvador, Brazil)
08:00P2190Sex-related differences in the systolic function in the setting of acute coronary syndromeNia SEMERDZIEVA (Sofia, Bulgaria)
08:00P2191A study of coronary flow response to nitroglycerin in patients with slow coronary flow syndrome and other types of non-obstructive coronary disease having diastolic dysfunctionNia SEMERDZIEVA (Sofia, Bulgaria)